Start page Newsroom All news Newsroom type All Releases Articles year All years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 The arbitrators dismissed Orion's claim in a dispute involving shares of Kronans Droghandel 12/20/2000 Press release 231,250 Orion A-shares converted into B-shares 12/12/2000 Stock exchange release Entire Board of Directors now composed of company-external members only 12/11/2000 Stock exchange release Announcement in accordance with section 10 of chapter 2 12/1/2000 Stock exchange release Orion Corporation Financial Reporting in 2001 11/20/2000 Stock exchange release Orion Group Interim Report 1-9/2000 11/7/2000 Stock exchange release 70,000 Orion A-shares converted into B-shares 10/26/2000 Stock exchange release Orion launching proprietary medicine again: Simdax (Levosimendan) approved in Sweden for severe heart failure 9/26/2000 Stock exchange release Tablet combining three Parkinson's Disease drugs within one being developed by Orion Pharma. Marketing agreement with Novartis. 9/7/2000 Stock exchange release Conversion of A-shares into B-shares 8/21/2000 Stock exchange release Orion Group Interim Report 1-6/2001 8/8/2000 Stock exchange release Orion Pharma sells certain assets of its infusion business to Baxter 7/6/2000 Press release Oriola authorised to wholesale pharmaceuticals in Sweden 6/16/2000 Press release Orion Pharma negotiates on selling selected assets of its infusion business 6/14/2000 Press release Jukka Viinanen appointed President of Orion Corporation 6/2/2000 Stock exchange release Announcement in accordance with section 10 of chapter 2 of the Finnish Securities Market Act 5/30/2000 Stock exchange release Orion and Innothéra settle their dispute regarding 5/16/2000 Stock exchange release Orion Group Interim Report 1-3/2000 5/5/2000 Stock exchange release